Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use
- PMID: 6149589
- DOI: 10.1007/BF00428544
Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use
Abstract
The reinforcing properties of delta 9THC (17.5 mg), a 1 g marijuana cigarette containing 1.83% delta 9-THC, a synthetic cannabis compound (Nabilone 2 mg orally), and their respective placebos were assessed with self-report and operant work-contingent choice procedures. Three groups of eight subjects were selected on the basis of a history of regular, intermittent, or occasional marijuana-smoking behavior. All subjects served as their own controls for each drug condition and studies were carried out under double-blind and "double-dummy" conditions in a controlled, residential research ward. Placebo responding did not vary as a function of history of marijuana use, but the past history of drug use had a significant influence on the reinforcing properties of cannabis compounds as well as the behavioral and physiological effects of these drugs. Regular marijuana users reported a significant increase in elation following marijuana smoking, but this was not associated with a significant increment in pulse rate. Intermittent and occasional marijuana smokers had significant increases in pulse rate, but no significant marijuana-induced elation. Nabilone and delta 9-THC produced a significant increase in pulse rate for all subject groups, but there was no significant increase in elation following ingestion of these compounds. Given a choice between the three drugs and three placebos, 18 of 23 subjects worked to obtain a marijuana cigarette in an operant work choice paradigm. These data indicate that smoked marijuana was significantly more reinforcing than all other cannabis compounds studied, regardless of past drug-use history.
Similar articles
-
Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.Psychopharmacology (Berl). 1992;107(2-3):255-62. doi: 10.1007/BF02245145. Psychopharmacology (Berl). 1992. PMID: 1319601 Clinical Trial.
-
Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males.Pharmacol Biochem Behav. 1984 Jan;20(1):103-6. doi: 10.1016/0091-3057(84)90109-6. Pharmacol Biochem Behav. 1984. PMID: 6320226 Clinical Trial.
-
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.Drug Alcohol Depend. 2011 Jul 1;116(1-3):86-92. doi: 10.1016/j.drugalcdep.2010.11.019. Epub 2011 Jan 11. Drug Alcohol Depend. 2011. PMID: 21227600 Free PMC article. Clinical Trial.
-
Self-administration of cannabinoids by experimental animals and human marijuana smokers.Pharmacol Biochem Behav. 2005 Jun;81(2):285-99. doi: 10.1016/j.pbb.2005.01.026. Pharmacol Biochem Behav. 2005. PMID: 15932767 Free PMC article. Review.
-
Behavioral and electroencephalographic correlates of the chronic use of marijuana--a review.Behav Biol. 1977 Oct;21(2):163-96. doi: 10.1016/s0091-6773(77)90297-8. Behav Biol. 1977. PMID: 334157 Review. No abstract available.
Cited by
-
Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.Psychopharmacology (Berl). 1992;107(2-3):255-62. doi: 10.1007/BF02245145. Psychopharmacology (Berl). 1992. PMID: 1319601 Clinical Trial.
-
Cannabis and Athletic Performance.Sports Med. 2021 Sep;51(Suppl 1):75-87. doi: 10.1007/s40279-021-01505-x. Epub 2021 Sep 13. Sports Med. 2021. PMID: 34515970 Free PMC article. Review.
-
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.Neuropsychopharmacology. 2013 Jul;38(8):1557-65. doi: 10.1038/npp.2013.54. Epub 2013 Feb 26. Neuropsychopharmacology. 2013. PMID: 23443718 Free PMC article.
-
Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.J Exp Anal Behav. 1994 Mar;61(2):203-11. doi: 10.1901/jeab.1994.61-203. J Exp Anal Behav. 1994. PMID: 8169569 Free PMC article. Clinical Trial.
-
The influence of drug class on reward in substance use disorders.Pharmacol Biochem Behav. 2024 Jul;240:173771. doi: 10.1016/j.pbb.2024.173771. Epub 2024 Apr 24. Pharmacol Biochem Behav. 2024. PMID: 38670466 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous